THE WOODLANDS, TX -- VGXI Inc., a Woodlands-based manufacturer of plasmid DNA - used in vaccine and gene therapy clinical trials - announced an expansion that will double its capacity and likely create jobs, according to VGXI Inc. Business Development Manager Christy Franco.
The expansion will add 3,000 square feet to the building, located at 2700 Research Forest Drive, and will include a small-scale cGMP (compliant with the U.S. Food and Drug Administration's current Good Manufacturing Practice regulations) production plant.
The expansion is in response to recent growth in the market for DNA-based pharmaceuticals.
"We've been seeing it coming," Franco said of the need to expand facilities. "Clients need quality DNA for clinical trials."
Read more from The Spring Observer, a Houston Community Newspaper partner